On Jul. 22, 2022, Gilead Sciences announced that the Committee for Medicinal Products for Human Use (CHMP) of…
On Jul. 22, 2022, the Centers for Disease Control and Prevention (CDC) released a MMWR report that summarized…
On Jul. 22, 2022, a team of scientists announced they had sequenced the genome of a 6,000-year-old citrullus…
On Jul. 21, 2022, the Oregon Department of Agriculture and the U.S. Department of Agricultureﾒs Animal Plant Health…
On Jul. 21, 2022, The New York State Department of Health confirmed that a case of paralytic poliomyelitis…
On Jul. 19, 2022, Novavax announced that it had signed agreements with its partner, SK bioscience, for the…
On Jul. 19, 2022, Novavax announced that the U.S. Centers for Disease Control and Prevention’s Advisory Committee on…
On Jul. 19, 2022, Gilead Sciences and the European Commission announced a new joint procurement agreement (JPA) that…
On Jul. 19, 2022, Yale scientists announced they had developed a novel Omicron-specific mRNA vaccine that offers superior…
On Jul. 19, 2022, the NIH announced that although COVID-19 booster vaccinations in adults elicit high levels of…
On Jul. 18, 2022, Moderna announced that the Therapeutic Goods Administration (TGA) in Australia had granted provisional registration…
On Jul. 17, 2022, Ghana announced the preliminary finding of two cases of Marburg virus disease and if…
On Jul. 15, 2022, The largest sustained decline in childhood vaccinations in approximately 30 years has been recorded…
On Jul. 14, 2022, Moderna announced that Health Canada had approved the use of Moderna’s mRNA COVID-19 vaccine,…
On Jul 14. 2022, Aegis Sciences announced it is was authorized to begin testing for monkeypox using the…
On Jul. 13, 2022, Quest Diagnostics announced that it had announced the nationwide availability* of the company’s lab-developed…
On Jul. 13, 2022, Novavax announced that the European Commission had approved the expanded conditional marketing authorization (CMA)…
On Jul. 13, 2022, Novavax announced that its COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) had received emergency use authorization from…
On Jul 13. 2022, Quest Diagnostics announced the nationwide availability of the company’s lab-developed molecular diagnostic test to…
On Jul. 11, 2022, Moderna announced new clinical data on its bivalent Omicron (BA.1) booster candidate, mRNA-1273.214. One…
On Jul. 11, 2022, Novavax announced an agreement with the U.S. Department of Health and Human Services, in…
On Jul. 11, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) launched an early-stage clinical trial…
On Jul. 8, 2022, Pfizer and BioNTech announced that the companies had submitted a variation to the European…
On Jul. 8, 2022, the U.S. Department of Agricultureﾒs Animal and Plant Health Inspection Service confirmed the stateﾒs…
On Jul. 8, 2022, the U.S. Department of Agricultureﾒs Animal and Plant Health Inspection Service confirmed the presence…
On Jul. 7, 2022, Ghana announced the preliminary finding of two cases of Marburg virus disease and if…
On Jul. 7, 2022, Novavax announced that the European Commission had approved a variation to allow SK bioscience…
On Jul. 6, 2022, LabCorp announced that it had begun testing for monkeypox using the U.S. Centers for…
On Jul. 5, 2022, Novavax announced announced that the European Commission had approved the expanded conditional marketing authorization…
On Jul. 5, 2022, Tgen and Northern Arizona University announced that a research team found that the vaccine…